OncoNano Medicine, Inc. — Form D/A

OncoNano Medicine, Inc. of Southlake, TX, a company, filed a Form D amendment with the SEC on 2021-06-17. The offering totals $60.0M, of which $49.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Joydeep GoswamiDirectorSouthlake, TX
Gina JonesDirectorVancouver, A1
John DyettDirectorSouthlake, TX
John DyettRelated PersonSouthlake, TX
Caleb SmithDirectorSouthlake, TX
Melissa PaoloniExecutive OfficerDallas, TX
Matthew HeadExecutive OfficerSouthlake, TX
Matthew HeadRelated PersonSouthlake, TX
Brett GiroirDirectorCollege Park, GA
Yumin QuiDirectorDallas, TX
Kartik KrishnanDirectorDallas, TX
Kartik KrishnanExecutive OfficerDallas, TX
Jeff KeyserExecutive OfficerSan Carlos, CA
Joydeep GoswamiRelated PersonSouthlake, TX
Ravi SrinivasanDirectorSouthlake, TX
Ravi SrinivasanExecutive OfficerSouthlake, TX
Ravi SrinivasanRelated PersonSouthlake, TX
Alvaro GuillemDirectorSouthlake, TX
Alvaro GuillemExecutive OfficerSouthlake, TX
Alvaro GuillemRelated PersonSouthlake, TX
Martin DriscollDirectorSouthlake, TX
Martin DriscollExecutive OfficerSouthlake, TX
Yumin QiuDirectorSouthlake, TX
Paritosh DhawaleDirectorSouthlake, TX
Paritosh DhawaleRelated PersonSouthlake, TX

Other filings by this issuer (6)

FiledFormOfferingSold
2025-06-02D$12.7M$12.7M
2021-11-03D/A$68.4M$68.4M
2021-03-26D/A$60.0M$26.4M
2020-10-21D$60.0M$21.5M
2019-04-22D/A$35.4M$33.9M
2018-03-28D$11.7M$11.7M

More